Mark Selby

13.8k citations
64 papers · 11.6k · 4 hit papers · h-index 46

Impact in

  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
  • Hepatology top 0.5%
    • Hepatitis C virus research

Papers in

    • Hepatitis C virus research 18
    • Cancer Immunotherapy and Biomarkers 14

Mark Selby

61 papers receiving 10.9k citations

Mark Selby's Hit Papers

In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primates 2014 · 534 citations
5340+14+29Years since publication5001k1.5k2k2.5k

Peers

Mark Selby
Comparison fields: 5 of 106
  • Oncology 4.5k
  • Hepatology 1.6k
  • Virology 464
  • Immunology 1.8k
  • Cellular and Molecular Neuroscience 700
Replace Gert Riethmüller with:
Gert Riethmüller Germany
Walter J. Storkus United States
Raymond G. Goodwin United States
Gert Riethmüller Germany
Boris Fehse Germany
Claudio Bordignon Italy
Clive R. Wood United States
Alice Oliffson Kamphorst United States
Yang Liu United States
Koji Tamada Japan
Mark Selby relative to Gert Riethmüller Germany Gert Riethmüller's profile →
Citations per field
00.5×2×4×6×7.7×
Gert Riethmüller · 1×
Citations per year

Countries citing papers authored by Mark Selby

Since Specialization
Citations

This map shows the geographic impact of Mark Selby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Selby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Selby more than expected).

Fields of papers citing papers by Mark Selby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Selby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Selby. The network helps show where Mark Selby may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Selby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Selby Line = papers co-authored together Mark Selby links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
Hit paper breakdown →
20102594
2
Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
Hit paper breakdown →
20111415
3
In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primates
Hit paper breakdown →
2014534
4 2000479
5
The highly polymorphic region near the human insulin gene is composed of simple tandemly repeating sequences
Hit paper breakdown →
1982459
6 1983428
7 1983425
8 2015343
9 1996294
10 2000273
11 2018273
12 2019270
13 2001225
14 2016199
15 1993196
16 1990194
17 1993187
18 2000165
19 1993164
20 2011144

About Mark Selby

Mark Selby is a scholar working on Hepatology, Oncology, Virology, Immunology and Cellular and Molecular Neuroscience, having authored 64 papers that have together received 11.6k indexed citations. Recurring topics across this work include Hepatitis C virus research (18 papers), Cancer Immunotherapy and Biomarkers (14 papers), Immunotherapy and Immune Responses (9 papers), HIV Research and Treatment (7 papers), Nerve injury and regeneration (5 papers), RNA and protein synthesis mechanisms (3 papers), T-cell and B-cell Immunology (3 papers) and Pancreatic function and diabetes (2 papers). The work is most often cited by research in Oncology (4.5k citations), Hepatology (1.6k citations), Virology (464 citations), Immunology (1.8k citations) and Cellular and Molecular Neuroscience (700 citations). Mark Selby has collaborated with scholars based in United States, Australia and Netherlands. Frequent co-authors include William J. Rutter, Alan J. Korman, Graeme I. Bell, Changyu Wang, Michael Houghton, Charles G. Drake, Robert H. Edwards, Robert A. Anders, Theresa M. Salay and Janis Marie Taube. Their work appears in journals such as Journal of Virology, The Journal of Immunology, Nature, Virology and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact